ALSPAC Focus @ 24+ Clinic

  • Research type

    Research Study

  • Full title

    ALSPAC Focus at 24+ Version 1

  • IRAS ID

    162562

  • Contact name

    Paul Burton

  • Contact email

    paul.burton@bristol.ac.uk

  • Sponsor organisation

    University of Bristol

  • Duration of Study in the UK

    2 years, 1 months, 31 days

  • Research summary

    The Avon Longitudinal Study of Parents and Children (ALSPAC) is one of the most detailed birth cohort studies ever conducted. It has gathered information and biological samples from mothers, their partners and their children (original children) since pregnancy throughout childhood and adolescence to the present day when at age 24 the participants are in early adulthood. More recently the study has been extended to include the children, siblings and grandparents of these original children. Human development, health and disease are affected by both genetic and environmental factors. ALSPAC has created a resource that scientists can use to explore the links between these factors. There is a dramatic increase in conditions that develop in childhood and have severe long−term effects such as diabetes and obesity. Such problems tend to run in families and have a genetic component and yet it is only environmental factors that can account for these changes. Therefore the DNA resource provides a unique opportunity to study genetic interactions with environmental exposures. In addition, ALSPAC can help identify the environmental conditions that can be changed in order to reduce such problems for future generations. The participants will be 24 years old when they attend the Focus @ 24+ clinic. This will be the tenth clinic to which the ALSPAC original children have been invited for behavioural/physical assessments. Focus @ 24+ will not only answer specific scientific questions but further enhance the value of ALSPAC as a scientific resource.

  • REC name

    South West - Frenchay Research Ethics Committee

  • REC reference

    14/SW/1173

  • Date of REC Opinion

    24 Feb 2015

  • REC opinion

    Further Information Favourable Opinion